** Shares of medical device maker Hologic HOLX.O fall 4.7%
to $79.77, the lowest since August
** HOLX said late on Monday it expects 2025 revenue in range
of $4.15 bln to $4.20 bln, below analysts' average estimate of
$4.21 bln - LSEG data
** Co said its full-year forecast included an expected
impact from ongoing temporary halt in shipping of its bone
density scanning machine, Horizon DXA systems
** Co reported Q4 adj. profit of $1.01/shr, in line with
analysts' estimates
** Stock up 11.6% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))